In the "BaoBab" project, DZNE researchers from Berlin and Bonn are developing a technical platform with which autoantibodies that cause brain diseases can be identified and investigated.…
Core KAP (Cooperation Unit for Applied Prevention Research)
Die Core KAP wird geleitet von
When the memory becomes weaker
Do you or your family members notice memory impairment or other mental…
DZNE scientists have identified a protein that regulates the growth of nerve fibers by pulling a brake.
Bonn/Germany, October 31, 2019. During embryonic development, nerve cells form thin, long…
The Munich biochemist Christian Haass has received the “Hartwig Piepenbrock-DZNE Prize” endowed with 60,000 euros.
Bonn, October 1, 2019. The Munich biochemist Christian Haass has received the…
According to an international study, the DZNE is one of the leading research institutions on Alzheimer’s disease in terms of publication count, citation rate, and collaborations with partners from…
Aufgabe der Stiftung ist es, Spenden einzuwerben, um die Demenzforschung und die Suche nach geeigneten Therapien am DZNE voranzutreiben.
Gemeinsame Pressemitteilung des Deutschen Zentrums für…
Dysfunctions in the maternal immune system that occur during pregnancy could possibly lead to impaired brain development in the unborn child. This is suggested by studies by the DZNE.
Joint Press…
Science for the Public
The annual science festival of the BMBF and the German Physical Society – termed „Highlights of Physics“– will be coming to Bonn this year on Sept. 16 – 21th, with the…
Researchers at the DZNE have found that a protein called TREM2 could positively influence the course of Alzheimer’s.
Munich/Germany, August 29, 2019. Researchers at the German Center for…
Prof. Thomas Gasser is new member of the Leopoldina
Thomas Gasser, head of clinical research at the DZNE in Tübingen and former site speaker, was recently accepted as a new academician of the German…
